This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Influenza

  1. This landscape of respiratory care equipment distributors across sub-Saharan Africa is intended to provide market insights into distributors in the region who can provide quality products and after-sales support. The distributors represented in this landscape were prioritized based on their geographic reach, quality assurance, and/or strong after-sales services. Each company completed a survey about their respective capabilities and engaged in follow-up discussions to further clarify their offerings. In this version (June 2021), products with stringent regulatory authority (SRA) approval were prioritized for inclusion. We will continue to build on this landscape as further engagement takes place.If your company supplies respiratory care equipment, has presence in sub-Saharan Africa, and would like to be considered for inclusion, please complete this short survey.
    Published: July 2021
    Type: Resource Page
  2. A great deal of knowledge already exists in the global health community regarding maternal, neonatal, and child health (MNCH) medical devices and the challenges/barriers they face. But this knowledge is currently scattered across a variety of donor, partner, country, and academic sources, and as a result, is not easily accessible to the broader community. As such, PATH—under the Market Dynamics for MNCH Medical Devices project (MD4MD)—conducted a rapid desk research exercise focused on compiling information that was either publicly available or easily accessible, including: published literature, multilateral organization resources (such as policy briefs, technical reports, and guidelines); implementing partner projects (such as assessments, landscapes, and technical reports); donor investment documents; and expert interviews with relevant project leads and medical device experts.This evidence review focuses on eight specific devices: (1) manual blood pressure cuff (sphygmomanometer); (2) electric bCPAP device; (3) neonatal resuscitation device; (4) x-ray radiography machine; (5) point-of-care hemoglobin meter; (6) infusion device; (7) ultrasound (app-based “pocket” devices); and (8) ultrasound (traditional portable devices).The goal of these documents is to (1) summarize for policymakers and health system leaders the most important barriers that MNCH devices face, and (2) highlight potential interventions and key knowledge gaps to prioritize with future investments.
    Published: July 2021
    Type: Resource Page
  3. Together with over 400 external stakeholders from across 50 countries, PATH has crafted a new institutional strategy that responds to the current crises we face as a global community, to the needs and priorities of our local partners, and to the resounding calls for the continued transformation of our sector. To bring our new strategy to life for our external partners, we’ve developed a strategy brochure. The brochure explains why PATH exists (our mission), what we will do (our priorities) and, perhaps most importantly, how we will do it (our change strategies).
    Published: June 2021
    Type: Resource Page
  4. The COVID-19 pandemic has highlighted the need for oxygen and other respiratory care supplies and equipment around the globe.In response, PATH conducted a biomedical equipment survey in eight government-owned health facilities in Zambia. The purpose of this survey was to quantify existing oxygen delivery and production equipment, consumables for administering oxygen therapy, bed capacity, and facility infrastructure characteristics that are relevant to providing respiratory care. The results indicated that all assessed institutions need urgent procurement of medical equipment for oxygen delivery, monitoring devices to support safe oxygen administration to patients, and accompanying consumables. Also, across all facilities there is insufficient staff trained to adequately manage COVID-19 patients requiring respiratory care.This report summarizes observations from the collected data and is intended to help global and national stakeholders understand COVID-19 treatment capacity in Zambia.
    Published: May 2021
    Type: Resource Page
  5. PATH has been a trusted partner to Vietnam’s Ministry of Health for four decades. We’ve supported its work to expand sexual, reproductive, maternal, and child health services, and to address infectious and vaccine-preventable diseases. Today, as rapid social and economic changes transform Vietnam, we are leveraging our thought leadership with the government, the private sector, civil-society organizations, and social entrepreneurs to advance equitable access to good health. Specific efforts include developing sustainable responses to diseases like HIV and tuberculosis (TB); supporting local stakeholders to develop their own health solutions, like domestically produced vaccines; and acting quickly to address new and emerging health threats, such as non-communicable diseases, hospital infections, drug resistance, and environmental dangers.
    Published: June 2019
    Type: Resource Page
  6. This fact sheet describes PATH’s work in maternal immunization—an approach of vaccinating during pregnancy to protect a mother and/or her infant. It covers work across vaccine projects targeting respiratory syncytial virus, Group B Streptococcus, influenza, and pertussis—infections that disproportionately threaten mothers and/or newborns.
    Published: May 2019
    Type: Resource Page
  7. Why is vaccination in pregnancy—or maternal immunization— important for public health? Here are 10 reasons.
    Published: May 2019
    Type: Article
  8. Scientists at PATH are leveraging a unique tool in new ways to develop more effective vaccines to combat some of the world's toughest diseases.
    Published: April 2019
    Type: Article
  9. Drug resistance is one of the biggest threats to global health today. Vaccines can help.
    Published: January 2019
    Type: Article
  10. This web page provides technical information, resources, and links relevant to microarray patch (also known as MAPs or microneedle patches) development of high priority vaccine and essential medicines. Includes multisectoral information for the community of microarray patch researchers, manufacturers, stakeholders, and technology developers.
    Published: November 2018
    Type: Resource Page
Load more